biology3 papersavg year 2025weak evidence

These limitations to further validate the therapeutic potential and safety of nano-curcumin formulations

Research gap analysis derived from 3 biology papers in our local library.

The gap

Future studies should address these limitations to further validate the therapeutic potential and safety of nano-curcumin formulations. Second, the long-term safety profile and potential toxicological effects of the nanoparticle Furthermore

Evidence profile

Sourced from the limitations and inline gaps and limitations section of the source papers, classified as general, drawn from work published between 2024 and 2026, spanning 3 journals. Those papers have been cited 12 times in total.

Research trend

Established — well-defined area with open sub-problems.

Supporting evidence — 3 representative gaps

  • Nano-Encapsulated Curcumin Improves Ovarian and Uterine Recovery from Cadmium Toxicity in Rats (2026) · The Open Biomedical Engineering Journal · doi

    Future studies should address these limitations to further validate the therapeutic potential and safety of nano-curcumin formulations. Second, the long-term safety profile and potential toxicological effects of the nanoparticle Furthermore, delivery system were not molecular mechanisms underlying the improved protective efficacy of nano-curcumin were not fully elucidated.

    generallimitations
    Keywords: potential safety nano curcumin future address limitations further validate therapeutic formulations second long term profile
  • Curcumin Alleviates Endometriosis in Sexually Mature Female Mice by Targeting PKA and Inhibiting De Novo Estrogen Synthesis (2026) · Biomedicines · doi

    Fourth, the study primarily focused on the PKA‑cAMP pathway, whereas curcumin likely acts through mul‑ tiple targets; future studies should explore its comprehensive network of actions. Addressing these limitations, future research should focus on (1) developing cur‑ cumin nano‑delivery systems to enhance its bioavailability and targeting; (2) utilizing patient‑derived xenograft (PDX) models or organoids to establish more clinically relevant EMs models; (3) applying proteomics and metabolomics to comprehensively map cur‑ cumin’s effects; (4) conducting prospective clinical trials to evaluate curcumin’s safety and efficacy in EMs patients.

    generalinline gaps
    Keywords: curcumin future cumin models fourth primarily focused camp pathway likely acts tiple targets explore comprehensive
  • Advancements in Utilizing Natural Compounds for Modulating Autophagy in Liver Cancer: Molecular Mechanisms and Therapeutic Targets (2024) · Cells · cited 12× · doi

    Potential drawbacks associated with NCs include the presence of inactive metabolic by-products, limited aqueous solubility, inadequate intrinsic activity, suboptimal absorption, and excessive metabolism. Natural compounds also exhibit diverse bioactivities, indicating their interaction with numerous molecular proteins. A Phase II clinical trial with curcumin demonstrated that elevated doses of curcumin can induce gastrointestinal discomfort, skin inflammation, and chest tightness in advanced pancreatic cancer patients.

    generallimitations sectionevidence 5/5
    Keywords: potential drawbacks associated ncs include presence inactive metabolic

Questions about this gap

Future studies should address these limitations to further validate the therapeutic potential and safety of nano-curcumin formulations. Second, the long-term safety profile and pot… This is supported by 3 representative gap statements extracted from 3 papers, rated weak evidence.

Explore this gap further

Run this gap as a query across open scholarly engines for the latest related literature.

Working on this gap? Review it with us.

AI Review reads your manuscript in one pass with 8 specialist agents, calibrated on 69K+ real peer reviews.

Related gaps in Biology

Command palette

Jump anywhere, run any action.